Alkermes to buy Avadel for up to $2.1Bnews2025-10-22T19:27:45+00:00October 22nd, 2025|Endpoints News|
Ipsen to buy ImCheck for €350M to get ‘superfamily’ of immunotherapiesnews2025-10-22T10:28:46+00:00October 22nd, 2025|Endpoints News|
Takeda makes major bispecific, ADC pact with Innovent for $1.2B upfrontnews2025-10-22T07:31:10+00:00October 22nd, 2025|Endpoints News|
Genmab was one of three bidders before inking $8B Merus acquisitionnews2025-10-22T01:54:06+00:00October 22nd, 2025|Endpoints News|
Grail raises $325M from Hims and others ahead of FDA bidnews2025-10-21T18:46:51+00:00October 21st, 2025|Endpoints News|
Robotic pill maker Rani teams up with Chugai in deal worth up to $1.08Bnews2025-10-17T15:21:42+00:00October 17th, 2025|Endpoints News|
Roche inks $80M upfront deal for Hansoh’s cancer ADCnews2025-10-17T09:41:33+00:00October 17th, 2025|Endpoints News|
Trump announces ‘most favored nation’ deal with EMD Serono to boost IVF accessnews2025-10-16T21:42:18+00:00October 16th, 2025|Endpoints News|
I-Mab remakes itself, with plans for Hong Kong listing, retinal R&D, and a new namenews2025-10-16T20:05:59+00:00October 16th, 2025|Endpoints News|
Pregene lands up to $1.52B deal with Kite for in vivo therapiesnews2025-10-16T19:25:26+00:00October 16th, 2025|Endpoints News|
